Clinical Trials Browser

Phase 2 × OTHER_GOV × Bortezomib × Clear all

NCT04433156 2023-05-18

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell, Marginal Zone